Systematic Assessment of Immune Marker Variation in Type 1 Diabetes: A Prospective Longitudinal Study

Immune analytes have been widely tested in efforts to understand the heterogeneity of disease progression, risk, and therapeutic responses in type 1 diabetes (T1D). The future clinical utility of such analytes as biomarkers depends on their technical and biological variability, as well as their corr...

Descripción completa

Detalles Bibliográficos
Autores principales: Speake, Cate, Bahnson, Henry T., Wesley, Johnna D., Perdue, Nikole, Friedrich, David, Pham, Minh N., Lanxon-Cookson, Erinn, Kwok, William W., Sehested Hansen, Birgit, von Herrath, Matthias, Greenbaum, Carla J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753618/
https://www.ncbi.nlm.nih.gov/pubmed/31572352
http://dx.doi.org/10.3389/fimmu.2019.02023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753618/
https://www.ncbi.nlm.nih.gov/pubmed/31572352
http://dx.doi.org/10.3389/fimmu.2019.02023

Ejemplares similares